Put CV Risks With Triptans in Perspective
December 2022
You’ll be asked which patients should avoid triptans due to cardiovascular concerns.
Labeling says that triptans shouldn’t be used in patients with coronary artery disease, stroke, uncontrolled hypertension, etc.
This stems from the early 1990s when it was thought that MIs were caused by vasospasm. Patients with CV disease or uncontrolled hypertension were excluded from triptan trials.
Get concise advice on drug therapy, plus unlimited access to CE
Hospital Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote